![NATA](https://nata.com.au/files/2021/02/nata.png)
National Association of Testing Authorities, Australia
Scope of Accreditation
Douglass Hanly Moir Pathology
Sonic Healthcare Pty Ltd
Site
North Ryde – Division of Toxicology
Accreditation No.
2178
Site No.
25722
Date of Accreditation
01 Jun 2017
Contact
Ms Tuyen Chieu P: +61 (02) 98556042
Availability
Services available to external clients
Supervision
Not Applicable
Scope of Accreditation
North Ryde – Division of Toxicology
ISO/IEC 17025 (2017)
Legal
Service | Product | Determinant |
---|---|---|
Medico legal drug testing AS/NZS 4308:2008, appendix A On-site screening procedure - Testing performed at client sites | Urine | Amphetamine type substances; Benzodiazepines; Cannabis metabolites; Cocaine metabolites; Creatinine; Opiates |
Medico legal drug testing AS/NZS 4308:2008, section 2 Specimen collection, storage, handling and dispatch | Urine | Colour; Creatinine; Temperature; pH |
Medico legal drug testing AS/NZS 4308:2008, section 3 General laboratory requirements | Urine | General laboratory requirements as described in AS/NZS 4308 |
Medico legal drug testing AS/NZS 4308:2008, section 4 Laboratory screening procedures | Urine | Amphetamine type substances; Benzodiazepines; Cannabis metabolites; Cocaine metabolites; Creatinine; Urea; pH |
Medico legal drug testing AS/NZS 4308:2008, section 5 Laboratory confirmatory procedures | Urine | 7-Amino-clonazepam; 7-Amino-flunitrazepam; 7-Amino-nitrazepam; Diazepam; Nordiazepam; Oxazepam; Temazepam; α-Hydroxyalprazolam |
11-nor-δ-9-Tetrahydrocannabinol-9-carboxylic acid; 3,4-Methylenedioxyamphetamine (MDA); 3,4-Methylenedioxymethamphetamine (MDMA); 6-Acetylmorphine; Amphetamines; Benzoylecgonine (ecgonine benzoate); Codeine; Ecgonine methyl ester; Ephedrine; Fentanyl; Methylamphetamine; Morphine; Oxycodone; Oxymorphone; Phentermine; Propoxyphene; Pseudoephedrine (PSE); Tramadol | ||
Medico legal drug testing AS/NZS 4760, appendix A On-site screening test procedure | Oral fluid | Amphetamine type substances; Cocaine; Cocaine metabolites; Δ-9-Tetrahydrocannabinol (THC-Δ9) |
Medico legal drug testing AS/NZS 4760, appendix B Additional testing | Oral fluid | Benzodiazepines |
Medico legal drug testing AS/NZS 4760, section 2 Collection, storage, handling and dispatch | Oral fluid | Handling and dispatch; Sample collection and storage |
Medico legal drug testing AS/NZS 4760, section 3 General laboratory requirements | Oral fluid | General laboratory requirements as described in AS/NZS 4760 |
Medico legal drug testing AS/NZS 4760, section 4 Laboratory screen testing | Oral fluid | Amphetamine type substances; Cocaine; Cocaine metabolites; Opiates; Δ-9-Tetrahydrocannabinol (THC-Δ9) |
Medico legal drug testing AS/NZS 4760, section 5 Laboratory confirmatory procedures | Oral fluid | 3,4-Methylenedioxyamphetamine (MDA); 3,4-Methylenedioxymethamphetamine (MDMA); 6-Acetylmorphine; Alprazolam; Amphetamines; Benzoylecgonine (ecgonine benzoate); Clonazepam; Cocaine; Codeine; Diazepam; Ecgonine methyl ester; Methylamphetamine; Morphine; Nitrazepam; Nordiazepam; Oxazepam; Oxycodone; Temazepam; Δ-9-Tetrahydrocannabinol (THC-Δ9) |
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
2178
Site No.
25722
Print date
31 Aug 2024
END OF SCOPE